Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride

Journal of Hospital Infection

Volumn 54, Issue 4, 2003, Pages 305-309

  Rohr, U ^a,b   Mueller, C ^b   Wilhelm, M ^b   Muhr, G ^a   Gatermann, S ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

MRSA; Mupirocin; Octenidine dihydrochloride; Topical clearance

Indexed keywords

CHLORHEXIDINE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; OCTENIDINE; OCTENISEPT; OFLOXACIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; TURIXIN; VANCOMYCIN; ANTIINFECTIVE AGENT; PYRIDINE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; AXILLA; BACTERIAL COLONIZATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; ERADICATION THERAPY; FOREHEAD; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INGUINAL REGION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NECK; NONHUMAN; NOSE; SAMPLING; SKIN ULCER; SPINAL CORD INJURY; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; SURGICAL WARD; WOUND INFECTION; ANTIBIOTIC RESISTANCE; BACTERIAL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; GERMANY; HETEROZYGOTE; INFECTION CONTROL; INTRADERMAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MASS SCREENING; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PENICILLIN RESISTANCE; PREVALENCE; SKIN CARE; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CARRIER STATE; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; GERMANY; HOSPITALS, UNIVERSITY; HUMANS; INFECTION CONTROL; MASS SCREENING; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; PREVALENCE; PYRIDINES; SKIN CARE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0142212430     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(03)00140-3     Document Type: Article

References (16)

1. Ayliffe G.A.J. Recommendations for the control of methicillin-resistant Staphylococcus aureus (MRSA) 1996 World Health Organization
2. NN Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. Report of a combined working party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association J Hosp Infect 39 1998 253-290
3. NN Empfehlung zur Prävention und Kontrolle von methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am RKI Bundesgesundheitsbl- Gesundheitsforsch-Gesundheitsschutz 42 1999 954-958
4. Hudson I.R.B. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience J Hosp Infect 27 1994 81-98
5. Harbarth S. Dharan S. Liassine N. Herrault P. Auckenthaler R. Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus Antimicrobial Agents Chemother 43 1999 1412-1416
6. Scully B.E. Briones F. Gu J.-. Neu H.C. Mupirocin treatment of nasal staphylococcal colonization Arch Intern Med 152 1992 353-356
7. Parras F. Guerrero M.C. Bouza E. et-al. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 39 1995 175-179
8. Asensio A. Guerrero A. Quereda C. Lizán M. Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication Infect Control Hosp Epidemiol 17 1996 20-28
9. Sloot N. Siebert J. Höffler U. Eradication of MRSA from carriers by means of whole-body washing with an antiseptic in combination with mupirocin nasal ointment Int J Hyg Environ Health 202 1999 513-523
10. Semret M. Miller M.A. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains Infect Control Hosp Epidemiol 22 2001 578-580
11. Boyce J.M. MRSA patients: proven methods to treat colonization and infection J Hosp Infect 48 2001 S9-S14
12. Harbarth S. Liassine N. Dharan S. Herrault P. Auckenthaler R. Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus Clin Infect Dis 31 2000 1380-1385
13. Muder R.R. Brennen C. Wagener M.M. et-al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility Ann Int Med 114 1991 107-112
14. Crowcroft N. Maguire H. Fleming M. Peacock J. Thomas J. Methicillin-resistant Staphylococcus aureus: investigation of a hospital outbreak using a case-control study J Hosp Infect 34 1996 301-309
15. Coello R. Glynn J.R. Gaspar C. Picazo J.J. Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA J Hosp Infect 37 1997 39-46
16. Merrer J. Santoli F. Appéré-De Vecchi C. Tran B. De Jonghe B. Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit Infect Control Hosp Epidemiol 21 2000 718-723